Strides Pharma Science — Shareholder Meeting (February 2023)

6 slides from Strides Pharma Science's shareholder meeting presentation, Feb 6, 2023

Slide 1: Warm Welcome to the Shareholders
Warm Welcome to the Shareholders Strides Pharma Science Limited | Extraordinary General Meeting | February 06, 2023 Page 1
Slide 2: Agenda
Agenda Stelis Biopharma – Business Updates Fund raise Updates EGM Agenda Page 2
Slide 3: Stelis Biopharma business updates: lowlights and key highlights
Stelis Biopharma had a challenging year due to geopolitical issues leading to zero sales for Sputnik Light Vaccine; however, the base CDMO business had several milestones enabling success for the future; Stelis is expected to generate its maiden EBITDA in FY24. Lowlights due to unprecedented situati
Slide 4: Stelis fund raise and refinancing updates
Investors and Promoters commit ~₹6,451M investment in Stelis, of which ~₹4,738 M is received; Stelis guides for a positive EBITDA outcome in FY24 and is seeking refinancing of its existing loans ◎ Stelis is poised to build a robust business with high margins & promising returns, delivering significa
Slide 5: Agenda for EGM
Agenda for EGM Item 1 ◎ Security/ Corporate Guarantee to be continued for the borrowings of Stelis Biopharma Limited under Section 185 of the Companies Act, 2013 Item 2 ◎ Security/ Corporate Guarantee to be continued for the borrowings of Stelis Biopharma Limited under Regulation 23 of the SEBI (Lis
Slide 6: Thank You
8S Strides Thank You